Luis De Taboada

Luis De Taboada has extensive work experience in various technology and medical device companies. Luis is currently serving as the Chief Technology Officer at JelikaLite since December 2020. Prior to that, they worked as the VP of Advanced Research at DJO Global from December 2020 to April 2022.

From 2014 to 2020, Luis served as the Chief Technology Officer at LiteCure LLC, where they provided strategic technical leadership for the development of new products in the veterinary and medical device fields. Luis focused on creating a stable product pipeline for the diagnosis and treatment of critical diseases, enhancing modern technologies, and implementing best practices to improve product performance and business growth.

Before LiteCure LLC, Luis worked as the VP of Engineering at Banyan Biomarkers, Inc from 2011 to 2014. In this role, they oversaw the entire medical device R&D organization and was responsible for developing a customized Point-of-Care Diagnostics Platform for Brain Injury Bio-markers. Luis collaborated with board members and consulting partners to manage resources, ensured compliance with laws and regulations, and secured institutional investment.

Prior to Banyan Biomarkers, Inc, Luis held the position of VP of Research and Development at PhotoThera, Inc from 2001 to 2011. Luis also worked as the Director of New Product Development at Laser Mechanisms from 1998 to 2001, and as the VP of Engineering at Clinicon from 1997 to 1998.

Luis began their career at Medical Optics in 1986 as an Engineering Manager and served in that role for 11 years.

Overall, Luis De Taboada's work experience showcases their expertise in technology leadership, product development, and medical devices.

Luis De Taboada pursued their education from 1992 to 1996 at UC San Diego. During this period, they obtained a Master of Science in Electrical Engineering (MSEE) with a specialization in Applied Physics.